Giuseppe Garofano, Cesare Saitta, Giacomo Musso, Margaret F Meagher, Umberto Capitanio, Dhruv Puri, Mai Dabbas, Natalie Birouty, Kit L Yuen, Alessandro Larcher, Benjamin Baker, Riccardo Autorino, Savio D Pandolfo, Francesco Montorsi, Giovanni Lughezzani, Paolo Casale, Nicolò M Buffi, Ithaar H Derweesh
{"title":"Nomogram for predicting long-term survival in renal cell carcinoma patients undergoing thermal ablation.","authors":"Giuseppe Garofano, Cesare Saitta, Giacomo Musso, Margaret F Meagher, Umberto Capitanio, Dhruv Puri, Mai Dabbas, Natalie Birouty, Kit L Yuen, Alessandro Larcher, Benjamin Baker, Riccardo Autorino, Savio D Pandolfo, Francesco Montorsi, Giovanni Lughezzani, Paolo Casale, Nicolò M Buffi, Ithaar H Derweesh","doi":"10.1016/j.urolonc.2025.04.012","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Thermal Ablation (TA) represents a valid option for management of renal cortical neoplasms. Recognizing paucity of tools to predict overall survival (OS) for patients undergoing TA, we developed a nomogram to offer personalized OS predictions utilizing the National Cancer Database.</p><p><strong>Methods: </strong>We included patients diagnosed with primary renal tumors who underwent TA between 2004 and 2020. Cox proportional hazards (CPH) model included age, Charlson-Deyo Comorbidity Index (CCI), tumor size, insurance status, ethnicity, histology, and tumor grade. A nomogram was developed to predict OS at 1, 5, and 10 years using a multivariable CPH model. Model robustness was confirmed through bootstrap validation with 1,000 iterations. Model performance was evaluated using Harrell's C-index, calibration plots at 1, 5, and 10 years, and time-dependent area under the curve (AUC) from ROC curves for 1-, 5-, and 10-year OS predictions RESULTS: We identified 10,121 patients (median age: 69 years; median follow-up: 55 months). Significant predictors of worse OS included advanced age (Hazard Ratio [HR] = 1.04, P < 0.001), higher CCI (HR = 2.20, P < 0.001), larger tumor size (HR = 1.03, P < 0.001), non-private insurance (HR = 2.16, P < 0.001), high-grade (HR = 1.31, P < 0.001), and clear cell (HR = 1.14, P = 0.015). Bootstrap validation confirmed the stability of the model, which achieved a C-index of 0.68. Calibration plots showed agreement between predicted and observed survival probabilities at 1, 5, and 10 years, with AUC values of 0.70, 0.71, and 0.74, respectively.</p><p><strong>Conclusion: </strong>We constructed a nomogram incorporating clinical, pathological, and socioeconomic factors to offer personalized OS prediction for TA. Future research should focus on external validation and clinical implementation.</p>","PeriodicalId":23408,"journal":{"name":"Urologic Oncology-seminars and Original Investigations","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology-seminars and Original Investigations","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2025.04.012","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Thermal Ablation (TA) represents a valid option for management of renal cortical neoplasms. Recognizing paucity of tools to predict overall survival (OS) for patients undergoing TA, we developed a nomogram to offer personalized OS predictions utilizing the National Cancer Database.
Methods: We included patients diagnosed with primary renal tumors who underwent TA between 2004 and 2020. Cox proportional hazards (CPH) model included age, Charlson-Deyo Comorbidity Index (CCI), tumor size, insurance status, ethnicity, histology, and tumor grade. A nomogram was developed to predict OS at 1, 5, and 10 years using a multivariable CPH model. Model robustness was confirmed through bootstrap validation with 1,000 iterations. Model performance was evaluated using Harrell's C-index, calibration plots at 1, 5, and 10 years, and time-dependent area under the curve (AUC) from ROC curves for 1-, 5-, and 10-year OS predictions RESULTS: We identified 10,121 patients (median age: 69 years; median follow-up: 55 months). Significant predictors of worse OS included advanced age (Hazard Ratio [HR] = 1.04, P < 0.001), higher CCI (HR = 2.20, P < 0.001), larger tumor size (HR = 1.03, P < 0.001), non-private insurance (HR = 2.16, P < 0.001), high-grade (HR = 1.31, P < 0.001), and clear cell (HR = 1.14, P = 0.015). Bootstrap validation confirmed the stability of the model, which achieved a C-index of 0.68. Calibration plots showed agreement between predicted and observed survival probabilities at 1, 5, and 10 years, with AUC values of 0.70, 0.71, and 0.74, respectively.
Conclusion: We constructed a nomogram incorporating clinical, pathological, and socioeconomic factors to offer personalized OS prediction for TA. Future research should focus on external validation and clinical implementation.
期刊介绍:
Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.